Most families these days feel like they can barely make ends meet, never mind have anything left in their wallet to invest. The first step toward financial freedom is cutting expenses below your income. In …
Read the full story »Make more, save more, spend smarter, and keep more of what you earn
Stock market news & analysis
CPI-300 is a drug that has been developed by IntelGenx Corp. (NASDAQ:IGXT.OB) and its partner, Cary Pharmaceuticals, Inc, under the Collaborative Agreement signed by the two companies in 2007. The drug is used as an antidepressant with an increased strength and can be used to treat disorders associated with depression. Read the full story »
Strativa Pharmaceuticals is a subsidiary owned by the Par Pharmaceutical Companies, Inc. (NYSE:PRX), a specialty pharmaceutical company that is involved in the development, manufacturing and commercialization of both generic drugs and novel branded drugs.
On August 7, 2009, Cytomedix, Inc. (NYSE AMEX:GTF) announced that it has submitted to, the United Sates of America’s toughest regulator, the Food and Drug Administration (FDA) a 510(K) for its AutoloGel™ Platelet Separation System. …
On January 4, 2010, NeoPharm, Inc. (NASDAQ:NEOL.PK), a biopharmaceutical company that discovers, develops and markets drugs for treating patients suffering from cancer and other life threatening diseases, disclosed that it has submitted an investigational new …
On August 3, 2009, Bovie Medical Corporation (AMEX:BVX) announced that it has submitted a 510(K) to the FDA, for its ICON VS electrosurgical generator, in order to obtain pre-market approval. We hope the company will …
Biomoda, Inc. (NASDAQ:BMOD.OB), whose headquarter is in Albuquerque, New Mexico, is a company that discovers and develops precise, safe and cheap in-vitro tests that diagnose cancer in the early stage – the period of time …
KRX-0401 (which is more popularly known by its generic name perifosone) is an anti-cancer drug that has been discovered and developed by Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Keryx, which has its headquarters in the New York …
On December 2, 2009 Novavax, Inc. (NASDAQ:NVAX) announced that it has received encouraging primary data from the first stage of the Phase 2 trial. The trial is being carried out on the company’s newly developed …
Nanosphere Inc. (NASDAQ:NSPH) is a pharmaceutical company that develops, manufactures and then brings into market “advanced molecular diagnostics systems” which detect “multiplexed direct genomic and ultra-sensitive protein detection”. All its products are based on the …
On December 29, 2009, AspenBio Pharma, Inc. (NASDAQ: APPY), which is a growing bio science company that develops innovative tests and drugs for the betterment of mankind, disclosed information about the Premarket Notification 510(K) that …
Most families these days feel like they can barely make ends meet, never mind have anything left in their wallet to invest. The first step toward financial freedom is cutting expenses below your income. In …
